Who has invested in Vestaron?

Anterra Capital, CGC Ventures, Novo Holdings are named among the investors backing Vestaron.

Vestaron Funding: $285M Raised, Series D (2024)

Vestaron funding overview

Vestaron is a Biotech company based in Durham, NC. Vestaron has raised $285M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in June 2024. The round record for Vestaron runs through 2024; nothing later has been disclosed. Investors on record include Anterra Capital, CGC Ventures, Novo Holdings. 3 distinct backers are named across the disclosed rounds.

Vestaron at a glance

Total raised: $285M
Latest round: Series D
Latest round date: June 2024
Industry: Biotech
Headquarters: Durham, NC
Notable investors: Anterra Capital, CGC Ventures, Novo Holdings

Frequently asked about Vestaron funding

How much has Vestaron raised?: Vestaron has raised $285M in total disclosed funding across the rounds on record.
Who has invested in Vestaron?: Anterra Capital, CGC Ventures, Novo Holdings are named among the investors backing Vestaron.
What was the latest Vestaron funding round?: The most recent disclosed round is a Series D, announced in June 2024.
Where is Vestaron based?: Vestaron is based in Durham, NC.
What sector does Vestaron operate in?: Vestaron is tracked under Biotech from Durham, NC, with $285M in disclosed funding.
When did Vestaron last raise?: The last disclosed Vestaron round closed in June 2024 at Series D.

Round data for Vestaron is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Durham and backer lists below.

Vestaron Funding: $285M Raised, Series D (2024)

Vestaron funding overview

Vestaron at a glance

Frequently asked about Vestaron funding

Companies related to Vestaron (40)

Browse related funding lists (5)